IHE (IHE) Stock Price & Analysis
IHE (IHE) rose 1.30% to USD 93.79 as of June 10, 2026 at 10:30 UTC, according to Nexqual real-time market data.
IHE last closed at USD 92.59; the session ranged USD 92.94–94.05 on volume of 76,168 shares. Market capitalization is —, with a 52-week range of USD 64.46–94.23 (PCX). Source: Nexqual, June 10, 2026 at 10:30 UTC.
Key Statistics (as of June 10, 2026 at 10:30 UTC)
| Price | USD 93.79 |
|---|---|
| Change | ▲ 1.30% (up) |
| Previous Close | USD 92.59 |
| Open | USD 93.28 |
| Day Range | USD 92.94 – 94.05 |
| 52-Week Range | USD 64.46 – 94.23 |
| Volume | 76,168 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IHE)
Nexqual's technical model rates IHE "STRONG BUY" based on 5 bullish and 0 bearish signals across 123 daily candles, as of June 10, 2026 at 10:30 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.93 (neutral) |
| vs SMA50 | Above (USD 88.35) |
| MACD | 1.08 (positive) |
Financial Health Score (IHE)
Nexqual rates IHE's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:30 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IHF | iShares U.S. Health Care Provid | USD 53.19 | ▲ 2.43% |
| XPH | State Street SPDR S&P Pharmaceu | USD 58.29 | ▲ 2.19% |
| PJP | Invesco Pharmaceuticals ETF | USD 112 | ▲ 1.09% |
| IYH | iShares U.S. Healthcare ETF | USD 64.93 | ▲ 1.07% |
| IHI | iShares U.S. Medical Devices ET | USD 50.94 | ▲ 1.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:30 UTC. This page is informational and not investment advice.